Literature DB >> 7782032

Lymph node metastasis and surgical management of gastric cancer invading the esophagus.

Y Yonemura1, K Tsugawa, L Fonseca, S Fushida, H Matsumoto, I Ninomiya, K Sugiyama, T Fujimura, G Nishimura, K Miwa.   

Abstract

In 88 resected patients with esophagus-invading gastric cancer, the factors determining the prognosis of this disease were investigated by multivariate analysis. Neither, age, sex, macroscopic type, thoracotomy, nor histological type proved to be independent prognostic factors. The presence or absence of lymph node metastasis, serosal invasion, tumor size, and the extent of esophageal invasion were found to be significant independent prognostic factors. Among lymph node metastases, involvement of para-aortic lymph nodes was especially important. The prognosis was significantly better in cases in which these nodes were carefully dissected (R4 gastrectomy), than in cases in which selected dissection was performed (R2). However, no patient with mediastinal lymph node metastasis survived for any lengthy period, and thus the mediastinal lymph nodes seemed to be nodes, the dissection of which brought little effect. Postoperative results were very poor in cases in which the extent of the esophageal invasion was 3 cm or more. These patients should be treated with multi-modal therapy such as neoadjuvant chemotherapy.

Entities:  

Mesh:

Year:  1995        PMID: 7782032

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  15 in total

Review 1.  Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies.

Authors:  Shinichi Hasegawa; Takaki Yoshikawa
Journal:  Gastric Cancer       Date:  2010-07-03       Impact factor: 7.370

2.  Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma.

Authors:  Shuji Takiguchi; Yasuhiro Miyazaki; Kohei Murakami; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2015-10-19       Impact factor: 2.549

3.  Comparison of the clinicopathological characteristics and the survival outcomes between the Siewert type II/III adenocarcinomas.

Authors:  Wei-Han Zhang; Xin-Zu Chen; Kai Liu; Kumar Anil; Kun Yang; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Med Oncol       Date:  2014-07-15       Impact factor: 3.064

4.  Sentinel node mapping in adenocarcinoma of the esophagogastric junction.

Authors:  Tatsuo Matsuda; Hiroya Takeuchi; Shinichi Tsuwano; Tadaki Nakahara; Makio Mukai; Yuko Kitagawa
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

5.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

6.  Optimal surgical management for esophagogastric junction carcinoma.

Authors:  Tatsuo Matsuda; Hiroya Takeuchi; Shinichi Tsuwano; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Hirofumi Kawakubo; Yoshiro Saikawa; Tai Omori; Yuko Kitagawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-02-26

7.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

8.  Prognosis of upper-third gastric carcinoma patients with invasion of the lower esophagus.

Authors:  Seong Yeob Ryu; Jae Kyoon Joo; Jae Hyuk Lee; Dong Yi Kim
Journal:  Langenbecks Arch Surg       Date:  2008-05-16       Impact factor: 3.445

9.  Characteristics of gastric cancer with esophageal invasion and aspects of surgical treatment.

Authors:  Kohei Wakatsuki; Tomoyoshi Takayama; Masato Ueno; Sohei Matsumoto; Koji Enomoto; Tetsuya Tanaka; Yoshiyuki Nakajima
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

10.  Crossroads in the combined-modality management of gastroesophageal junction carcinomas.

Authors:  Smith Apisarnthanarax; Joel E Tepper
Journal:  Gastrointest Cancer Res       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.